Corrigendum: Dual-specificity phosphatase CDC25B was inhibited by natural product HB-21 through covalently binding to the active site
Shoude Zhang
Qiangqiang Jia
Qiang Gao1 
Yuxin Weng
Zhanhai Su- 1State Key Laboratory of Plateau Ecology and Agriculture, Qinghai University, Xining, China
- 2Department of Pharmacy, Medical College of Qinghai University, Xining, China
A Corrigendum on
Dual-specificity phosphatase CDC25B was inhibited by natural product HB-21 through covalently binding to the active site
by Zhang S, Jia Q, Gao Q, Fan X, Weng Y and Su Z (2018). Front. Chem. 6:531. doi: 10.3389/fchem.2018.00531
In the original article, there was an error in the affiliations as published, in which a third affiliation was wrongly included for author “Shoude Zhang”. The correct affiliations appear above.
In the original article, there was an error in Figure 6, page 4, as published. In the same batch of experiments, WB experiments for two compounds were done at the same time, and the article incorrectly used the results of another drug in the experiments. The corrected Figure 6 and its caption appear below.
FIGURE 6. Inhibition of CDK1 dephosphorylation caused by HB-21. The cells in the G2/M phase were treated with the indicated concentration of HB-21 or DMSO for 4 h, and then harvested. The samples were processed for Western blot analysis.
The authors apologize for these errors and state that this does not change the scientific conclusions of the article in any way. The original article has been updated.
Publisher’s note
All claims expressed in this article are solely those of the authors and do not necessarily represent those of their affiliated organizations, or those of the publisher, the editors and the reviewers. Any product that may be evaluated in this article, or claim that may be made by its manufacturer, is not guaranteed or endorsed by the publisher.
Keywords: Cdc25B inhibitor, sesquiterpene lactone, anticancer, cell cycle progression, covalent binding to protein
Citation: Zhang S, Jia Q, Gao Q, Fan X, Weng Y and Su Z (2022) Corrigendum: Dual-specificity phosphatase CDC25B was inhibited by natural product HB-21 through covalently binding to the active site. Front. Chem. 10:1082236. doi: 10.3389/fchem.2022.1082236
Received: 31 October 2022; Accepted: 10 November 2022;
Published: 18 November 2022.
Edited and reviewed by:
Michael Kassiou, The University of Sydney, AustraliaCopyright © 2022 Zhang, Jia, Gao, Fan, Weng and Su. This is an open-access article distributed under the terms of the Creative Commons Attribution License (CC BY). The use, distribution or reproduction in other forums is permitted, provided the original author(s) and the copyright owner(s) are credited and that the original publication in this journal is cited, in accordance with accepted academic practice. No use, distribution or reproduction is permitted which does not comply with these terms.
*Correspondence: Shoude Zhang, shoude.zhang@qhu.edu.cn; Zhanhai Su, suzhanhai@foxmail.com